HRT Financial’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
HRT Financial's IBER.U Position: Q1 2023 in Review
HRT Financial sold out of Ibere Pharmaceuticals Units (IBER.U) in Q1 2023, closing a stake of 64,980 shares — an estimated $649K sold.
HRT Financial first reported a position in IBER.U in Q1 2021 and held it in 8 quarters. The position peaked at $653K in Q2 2021. 0 funds tracked by Wall St. Rank hold IBER.U as of Q1 2023.
- HRT Financial reported no remaining Ibere Pharmaceuticals Units position as of Q1 2023 after selling out during the quarter.
- HRT Financial sold 64,980 Ibere Pharmaceuticals Units shares in Q1 2023, an estimated $649K.
- HRT Financial first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 8 quarters.
- HRT Financial's Ibere Pharmaceuticals Units position peaked at $653K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q1 2023.
Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.